2021
DOI: 10.1007/s12264-020-00620-5
|View full text |Cite
|
Sign up to set email alerts
|

Selective Ferroptosis Inhibitor Liproxstatin-1 Attenuates Neurological Deficits and Neuroinflammation After Subarachnoid Hemorrhage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
77
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 137 publications
(80 citation statements)
references
References 51 publications
3
77
0
Order By: Relevance
“…Importantly, increasing evidence suggests that ferroptosis could be the leading factor to induce ICH secondary injury. The ferroptosis inhibitors have become increasingly popular in ICH therapy recently (Cao et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Importantly, increasing evidence suggests that ferroptosis could be the leading factor to induce ICH secondary injury. The ferroptosis inhibitors have become increasingly popular in ICH therapy recently (Cao et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Currently, methods to monitor ferroptosis rely mainly on measuring ROS production, lipid peroxidation, iron accumulation, and abilities of ferroptosis inhibitors to block cell death [34][35][36]. According to the previous research results, the ferroptosis inhibitors, ferrostatin-1 and liproxstatin-1, have shown their therapeutic value in animal models of ICH; however, their "ROS inhibitor" roles hinted that they may inhibit other pathways of cell death at the same time [37][38][39]. It is particularly important to find more selective and safe drugs to promote ICH recovery, and ironchelating agents may be a potential treatment for ICHinduced ferroptosis.…”
Section: Discussionmentioning
confidence: 99%
“…Ferroptosis also plays an important role in early brain injury after SAH (Li et al, 2021). Cao et al (2021) recently reported that the treatment with lip-1 protected HT22 cells against hemin-induced injury and reduced neurological deficits and neuroinflammation after SAH in mice. Additionally, earlier research has verified that the NF-E2-related factor 2 (Nrf2) pathway, a multifunctional signaling pathway that can control more than 250 genetics (Chang et al, 2014), is activated and provides neuroprotection after SAH (Chen et al, 2020).…”
Section: Ferroptosis In Hemorrhagic Strokementioning
confidence: 99%